Ross Michael Jay 4
4 · Xilio Therapeutics, Inc. · Filed Oct 25, 2021
Insider Transaction Report
Form 4
ROSS MICHAEL JAY
Director
Transactions
- Award
Stock Option (right to buy)
2021-10-21+26,400→ 26,400 totalExercise: $16.00Exp: 2031-10-20→ Common Stock (26,400 underlying)
Footnotes (1)
- [F1]The option award was granted on October 21, 2021 and will vest in three equal installments on October 21, 2022, October 21, 2023 and October 21, 2024.